• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Management of post-transplant lymphoproliferative disorders.

作者信息

Dierickx Daan, Vergote Vibeke

机构信息

Department of Hematology, University Hospitals Leuven, Leuven, Belgium.

出版信息

Hemasphere. 2019 Jun 30;3(Suppl). doi: 10.1097/HS9.0000000000000226. eCollection 2019 Jun.

DOI:10.1097/HS9.0000000000000226
PMID:35309814
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8925657/
Abstract
摘要

相似文献

1
Management of post-transplant lymphoproliferative disorders.移植后淋巴细胞增生性疾病的管理
Hemasphere. 2019 Jun 30;3(Suppl). doi: 10.1097/HS9.0000000000000226. eCollection 2019 Jun.
2
Management and outcome of liver recipients with post-transplant lymphoproliferative disease.肝移植受者移植后淋巴组织增生性疾病的管理与结局
Hepatogastroenterology. 2000 Jan-Feb;47(31):211-9.
3
Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines.异基因造血干细胞移植后患者的爱泼斯坦-巴尔病毒感染及移植后淋巴增殖性疾病的管理：第六届欧洲白血病感染会议（ECIL-6）指南
Haematologica. 2016 Jul;101(7):803-11. doi: 10.3324/haematol.2016.144428.
4
Incidence and mortality of post-transplant lymphoproliferative disorders after kidney transplantation: A real-world retrospective analysis in Japan.肾移植后移植后淋巴组织增生性疾病的发病率和死亡率：日本真实世界回顾性分析。
Int J Urol. 2022 Mar;29(3):206-211. doi: 10.1111/iju.14750. Epub 2021 Dec 12.
5
Occurrence of post-transplant lymphoproliferative disorders among over thousand adult recipients: any role for hepatitis C infection?超过千名成年受者中移植后淋巴细胞增生性疾病的发生情况：丙型肝炎感染有何作用？
Eur J Gastroenterol Hepatol. 2006 Oct;18(10):1065-70. doi: 10.1097/01.meg.0000231752.50587.ae.
6
Post-Transplant Lymphoproliferative Disorder in Kidney Transplant Recipients: A Single-Center Experience in Japan.肾移植受者的移植后淋巴细胞增生性疾病：日本单中心经验
Ther Apher Dial. 2016 Apr;20(2):165-73. doi: 10.1111/1744-9987.12392. Epub 2016 Mar 7.
7
Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后与 EBV 相关的移植后淋巴增殖性疾病的危险因素。
Haematologica. 2014 Feb;99(2):346-52. doi: 10.3324/haematol.2013.087338. Epub 2013 Sep 20.
8
Post-transplant lymphoproliferative disease is associated with early sternotomy and left ventricular hypoplasia during infancy: a population-based retrospective review.移植后淋巴细胞增生性疾病与婴儿期早期胸骨切开术和左心室发育不全相关：一项基于人群的回顾性研究。
Cardiol Young. 2017 Nov;27(9):1823-1831. doi: 10.1017/S104795111700155X. Epub 2017 Aug 7.
9
Quantitative Epstein-Barr virus (EBV) serology in lung transplant recipients with primary EBV infection and/or post-transplant lymphoproliferative disease.肺移植受者原发性EB病毒（EBV）感染和/或移植后淋巴增殖性疾病的EBV定量血清学检测
J Med Virol. 2003 Feb;69(2):258-66. doi: 10.1002/jmv.10273.
10
Diverse clinical and histopathologic features of cutaneous post-transplant lymphoproliferative disorders: A presentation of two cases.皮肤移植后淋巴组织增生性疾病的多种临床和组织病理学特征：两例病例报告。
Australas J Dermatol. 2019 Nov;60(4):e317-e321. doi: 10.1111/ajd.13076. Epub 2019 May 29.

引用本文的文献

1
Post-transplant lymphoproliferative disease after pediatric kidney transplant.小儿肾移植后移植后淋巴细胞增生性疾病
Front Pediatr. 2022 Dec 7;10:1087864. doi: 10.3389/fped.2022.1087864. eCollection 2022.

本文引用的文献

1
Dual blockade of the PI3K/Akt/mTOR pathway inhibits posttransplant Epstein-Barr virus B cell lymphomas and promotes allograft survival.双重阻断 PI3K/Akt/mTOR 通路可抑制移植后 EBV B 细胞淋巴瘤并促进移植物存活。
Am J Transplant. 2019 May;19(5):1305-1314. doi: 10.1111/ajt.15216. Epub 2019 Jan 9.
2
Expression of PD-1, PD-L1, and PD-L2 in posttransplant lymphoproliferative disorder after solid organ transplantation.PD-1、PD-L1 和 PD-L2 在实体器官移植后移植后淋巴组织增生性疾病中的表达。
Leuk Lymphoma. 2019 Feb;60(2):376-384. doi: 10.1080/10428194.2018.1480767. Epub 2018 Jul 22.
3
Immunosuppression Is Associated With Clinical Features and Relapse Risk of B Cell Posttransplant Lymphoproliferative Disorder: A Retrospective Analysis Based on the Prospective, International, Multicenter PTLD-1 Trials.免疫抑制与 B 细胞移植后淋巴组织增生性疾病的临床特征和复发风险相关：基于前瞻性、国际、多中心 PTLD-1 试验的回顾性分析。
Transplantation. 2018 Nov;102(11):1914-1923. doi: 10.1097/TP.0000000000002269.
4
Post-Transplantation Lymphoproliferative Disorders in Adults.成人移植后淋巴增殖性疾病
N Engl J Med. 2018 Feb 8;378(6):549-562. doi: 10.1056/NEJMra1702693.
5
Bortezomib promotes KHSV and EBV lytic cycle by activating JNK and autophagy.硼替佐米通过激活 JNK 和自噬促进 KHSV 和 EBV 的裂解周期。
Sci Rep. 2017 Oct 12;7(1):13052. doi: 10.1038/s41598-017-13533-7.
6
Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial.利妥昔单抗诱导反应是 B 细胞移植后淋巴组织增生性疾病的预测标志物，并允许在一项国际性、前瞻性、多中心 II 期试验中成功分层为利妥昔单抗或 R-CHOP 巩固治疗。
J Clin Oncol. 2017 Feb 10;35(5):536-543. doi: 10.1200/JCO.2016.69.3564. Epub 2016 Dec 19.
7
Survival Analyses and Prognosis of Plasma-Cell Myeloma and Plasmacytoma-Like Posttransplantation Lymphoproliferative Disorders.浆细胞骨髓瘤和浆细胞瘤样移植后淋巴细胞增生性疾病的生存分析与预后
Clin Lymphoma Myeloma Leuk. 2016 Dec;16(12):684-692.e3. doi: 10.1016/j.clml.2016.09.002. Epub 2016 Sep 17.
8
Rituximab-based treatments followed by adoptive cellular immunotherapy for biopsy-proven EBV-associated post-transplant lymphoproliferative disease in recipients of allogeneic hematopoietic stem cell transplantation.基于利妥昔单抗的治疗，随后进行过继性细胞免疫治疗，用于经活检证实的异基因造血干细胞移植受者的EB病毒相关移植后淋巴增殖性疾病。
Oncoimmunology. 2016 Mar 10;5(5):e1139274. doi: 10.1080/2162402X.2016.1139274. eCollection 2016 May.
9
Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines.异基因造血干细胞移植后患者的爱泼斯坦-巴尔病毒感染及移植后淋巴增殖性疾病的管理：第六届欧洲白血病感染会议（ECIL-6）指南
Haematologica. 2016 Jul;101(7):803-11. doi: 10.3324/haematol.2016.144428.
10
Lenalidomide, Thalidomide, and Pomalidomide Reactivate the Epstein-Barr Virus Lytic Cycle through Phosphoinositide 3-Kinase Signaling and Ikaros Expression.来那度胺、沙利度胺和泊马度胺通过磷酸肌醇3激酶信号传导和IKAROS表达重新激活爱泼斯坦-巴尔病毒裂解周期。
Clin Cancer Res. 2016 Oct 1;22(19):4901-4912. doi: 10.1158/1078-0432.CCR-15-2242. Epub 2016 Jun 13.